usage of seabuckthorn seed oil for lowering high blood pressure

Randomized single-blind placebo controlled clinical trial to assess efficacy of seabuckthorn seed oil in hypertensive patients .

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/11/006368

Enrollment

100

Registered

2015-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: null- hypertension hypertension defined as systolic blood pressure of 140 mm Hg and above.

Interventions

Intervention1: seabuckthorn seed oil: 0.75ml/day given orally for 12 weeks Control Intervention1: sunflower seed oil: 0.75ml/day given orally for 12 weeks

Eligibility

Inclusion criteria

Inclusion criteria: hypertensive not taking or willing to take any prescribed drug for hypertensive.

Exclusion criteria

Exclusion criteria: history of coronary heart disease or stroke abnormal KFT LFT users of lipid lowering drugs or other anti hypentensive agents.

Design outcomes

Primary

Measure	Time frame
no mortality no adverse effect blood pressure less than 140 mm hgTimepoint: 12 weeks	—

Secondary

Measure	Time frame
Chol:HDL less than 4.97 mg/dl LDL:HDL less than 3.55 mg/dl CAVI cardio ankle vascular index total serum antioxidant levelTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Sunil Kumar Hota

DIHAR, DRDO

drsunilhota@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 12, 2026